Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.020
-0.070 (-6.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $76.50 million as of December 20, 2024. Its market cap has increased by 460.39% in one year.
Market Cap
76.50M
Enterprise Value
-8.06M
1-Year Change
460.39%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $76.50M, an increase of 49.91%. That is a compound annual growth rate of 13.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 76.50M | 324.01% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exagen | 83.07M |
| OS Therapies | 83.04M |
| Cibus | 82.79M |
| Theratechnologies | 82.17M |
| EDAP TMS | 81.45M |
| Karyopharm Therapeutics | 81.40M |
| Assertio Holdings | 80.49M |
| So-Young International | 79.71M |